Biohit Oyj
Develops diagnostic products for early disease detection, focusing on gastroenterology.
BIOBV | HE
Overview
Corporate Details
- ISIN(s):
- FI0009005482
- LEI:
- 74370089ATTSNBXJVT29
- Country:
- Finland
- Address:
- LAIPPATIE 1, FI-00880 HELSINKI
- Sector:
- Manufacturing
Description
Biohit Oyj is a global biotechnology company that develops, manufactures, and markets innovative diagnostic products and services. The company specializes in tools for the early diagnosis and prevention of diseases, with a primary focus on gastroenterology. Its key offerings include the GastroPanel® blood test for assessing stomach health and screening for risks of gastric cancer, as well as diagnostic tests for conditions such as Helicobacter pylori infection. Operating under the mission "Innovating for Health," Biohit's products are designed to support medical research, facilitate early and accurate diagnosis, and improve patient quality of life.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Type / Size | Actions | |
|---|---|---|---|---|---|
| 2014-02-27 07:30 |
BIOHIT GROUP FINANCIAL STATEMENT RELEASE 2013
|
Finnish | HTML • 46.0 KB | ||
| 2014-02-27 07:30 |
BIOHIT GROUP FINANCIAL STATEMENT RELEASE 2013
|
English | HTML • 46.6 KB | ||
| 2014-02-18 08:45 |
Biohit suspends trial aiming at H. pylori eviction
|
Finnish | HTML • 2.2 KB | ||
| 2014-02-18 08:45 |
Biohit suspends trial aiming at H. pylori eviction
|
English | HTML • 2.1 KB | ||
| 2013-12-23 14:00 |
Restructuring of Biohit Acetium distribution in Canada
|
Finnish | HTML • 4.3 KB | ||
| 2013-12-23 14:00 |
Restructuring of Biohit Acetium distribution in Canada
|
English | HTML • 4.1 KB | ||
| 2013-12-17 09:15 |
Biohit Oyj’s Option Scheme I 2013 – International Sales Management Option Arran…
|
Finnish | PDF • 377.6 KB | ||
| 2013-12-17 09:15 |
Biohit Oyj’s Option Scheme I 2013 – International Sales Management Option Arran…
|
English | PDF • 394.1 KB | ||
| 2013-11-20 06:30 |
Increased number of Biohit shares entered into trade register
|
Finnish | HTML • 2.7 KB | ||
| 2013-11-20 06:30 |
Increased number of Biohit shares entered into trade register
|
English | HTML • 2.6 KB | ||
| 2013-11-18 10:45 |
H-pylori-brochure-490062 2-EN-screen.pdf
|
Finnish | PDF • 1.2 MB | ||
| 2013-11-18 10:45 |
Biohit hankkii oikeudet helikobakteeri-infektion pikatestiin – ylivoimainen tes…
|
Finnish | HTML • 2.8 KB | ||
| 2013-11-18 10:45 |
H-pylori-brochure-490062 2-EN-screen.pdf
|
English | PDF • 1.2 MB | ||
| 2013-11-18 10:45 |
Biohit acquires rights to H. pylori quick test – new superior test to product r…
|
English | HTML • 2.9 KB | ||
| 2013-11-11 09:00 |
Biohit’s Chinese Joint Venture proceeding as planned
|
Finnish | HTML • 2.1 KB |
Automate Your Workflow. Get a real-time feed of all Biohit Oyj filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Biohit Oyj
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Biohit Oyj via our API.
Peer Companies
